Stocktoria
Bausch & Lomb Corp BLCO
NYSE · XNYS · stock · Ophthalmic Goods · website · IPO 2022-05-06
Bausch & Lomb Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 2.2% | 3.4% | 3.1% | 5.5% | 8.7% |
| Net margin | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% |
| FCF margin | -1.3% | -1.2% | -4.8% | 4.5% | 18.1% |
| Return on assets | -2.6% | -2.4% | -1.9% | 0.1% | 1.7% |
| Return on equity | -5.5% | -4.8% | -3.8% | 0.1% | 1.9% |
| Debt / equity | 0.77× | 0.73× | 0.66× | 0.34× | 0.00× |
| Current ratio | 1.55 | 1.60 | 1.74 | 1.65 | 1.49 |
| Revenue growth | 6.5% | 15.6% | 10.0% | 0.1% | — |
Source: SEC EDGAR filings · CIK 0001860742 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.